Effect of glucagon on glucose production, lipolysis, and gluconeogenesis in familial hyperinsulinism

Hormone Research

Volumn 50, Issue 2, 1998, Pages 94-98

  Cederblad, Fredrik ^a   Ewald, Uwe ^a   Gustafsson, Jan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Familial hyperinsulinism, infant; Glucagon; Glucose production; Glycerol; Nesidioblastosis; Stable isotope

Indexed keywords

GLUCAGON; GLUCOSE; GLYCEROL; STABLE ISOTOPE;

ARTICLE; CASE REPORT; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGENOLYSIS; HUMAN; HYPERINSULINISM; LIPOLYSIS; MALE; NEWBORN; PRIORITY JOURNAL;

DRUG COMBINATIONS; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLYCEROL; HUMANS; HYPERINSULINISM; INFANT, NEWBORN; KINETICS; LIPOLYSIS; MALE; PROTAMINES; TREATMENT OUTCOME;

EID: 0031660427     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023242     Document Type: Article

References (21)

1. Thomas PM, Cote GJ, Wohlik N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J: Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268:426-429.
2. Glaser B, Chiu KC, Anker R, Nestorowicz A, Landau H, Ban-Bassat H, Shlomai Z, Kaiser N, Thornton PS, Stanley CA, Spielman RS, Gogolin-Ewens K, Cerasi E, Baker L, Rice J, Donis-Keller H, Permutt MA: Familial hyperinsulinism maps to chromosome 11p14-15.1 30 cM centromeric to the insulin gene. Nat Genet 1994;7:185-188.
3. Thornton PS, Summer AE, Ruchelli ED, Spielman RS, Baker L, Stanley CA: Familial and sporadic hyperinsulinism: Histologic finding and segregation analysis support a single autosomal recessive disorder. J Pediatr 1991;119: 721-724.
4. Landau H, Schiller M: Persistent hyperinsulinemic hypoglycemia of infance and childhood; in Schiller M (ed): Pediatric Surgery of the Liver, Pancreas and Spleen. Philadelphia, Saunders, 1991, pp 187-201.
5. Aynsley-Green A, Polak JM, Bloom SR, Gough MH, Keeling J, Ashcroft SJ, Turner RC, Baum JD: Nesidioblastosis of the pancreas: Definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycemia. Arch Dis Child 1981;56:496-508.
6. Baker L, Thornton PS, Stanley CA: Management of hyperinsulinism in infants. J Pediatr 1991;119:755-757.
7. Thornton PS, Alter CA, Katz LE, Baker L, Stanley CA: Short-and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr 1993;123:637-643.
8. Daneman D, Ehrlich RM: The enigma of persistent hyperinsulinemic hypoglycemia of infancy. J Pediatr 1993;123:573-575.
9. Rose SR, Chrousos G, Cornblath M, Sidbury J: Management of postoperative nesidioblastosis with zinc protamine glucagon and oral starch. J Pediatr 1986;108:97-100.
10. Aynsley-Green A, Polak JM, Bloom SR: Nesidioblastosis of the pancreas in the infancy. Dev Med Child Neurol 1981;23:372-379.
11. Kuhl C, Hvorslev V, Tygstrup I, Lindkaer-Jensen S: Elevated serum proinsulin in beta cell nesidioblastosis: Report of a case in a newborn. Scand J Gastroenterol 1979;53(suppl):49-52.
12. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P: An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age. Acta Paediatr Scand 1991;80: 756-762.
13. Hocking MD, Newell SJ, Ranyer PH: Use of human growth hormone in treatment of nesidioblastosis in a neonate. Arch Dis Child 1986; 61:706-707.
14. Food and Drug Administration: Guideline on Validation of the Limulus Amebocyte Lysate Test as End-product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products and Medical Devices. Washington, Food and Drug Andministration, 1987.
15. Sunehag A, Ewald U, Larsson A, Gustaffson J: Glucose production rat ein extremely immature neonates (<28 weeks) studied by the sue of deuterated glucose. Pediatr Res 1993;33:97-100.
16. Fjeld CR, Cole FS, Bier DM: Energy expenditure, lipolysis and glucose production in preterm infants treated with theophylline. Pediatr Res 1992;32:693-698.
17. Sunehag A, Ewald U, Gustafsson J: Extremely preterm infants are capable of gluconeogenesis from glycerol on their first day of life. Pediatr Res 1996;40:553-557.
18. Mehta A, Wootton R, Cheng KN, Penfold P, Halliday D, Stacey TE: Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycemia. Arch Dis Child 1987;62:924-930.
19. Bourgnères PF, Karl IE, Hillman LS, Bier DM: Lipid transport in the human newborn: Palmitate and glycerol turnover and the contribution of glycerol to neonatal hepatic glucose output. J Clin Invest 1982;70:262-270.
20. Patel D, Kalhan S: Glycerol metabolism and triglyceride-fatty acid cycling in the human newborn: Effect of maternal diabetes and intrauterine growth retardation. Pediatr Res 1992; 31:52-58.
21. Lindley KJ, Dunne MJ, Kane C, Shepherd RM, Squires PE, James RFL, Johnson PRV, Eckhardt S, Wakeling E, Dattani M, Milla PJ, Aynsley-Green A: Ionic control of β-cell function in nesidioblastosis: A possible therapeutic role for calcium channel blockade. Arch Dis Child 1996;74:373-378.